| Related Articles |
Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients.
Clin Infect Dis. 2020 Apr 07;:
Authors: Perinel S, Launay M, Botelho-Nevers É, Diconne É, Louf-Durier A, Lachand R, Murgier M, Page D, Vermesch R, Thierry G, Delavenne X
Abstract
Hydroxychloroquine (HCQ) appears to be a promising treatment for COVID-19. However, all ongoing clinical trials with HCQ use different dosing regimens, resulting on various concentrations PK studies are therefore needed to define the optimal dosing regimen.
PMID: 32255489 [PubMed - as supplied by publisher]